MX2016016371A - Nuevos compuestos. - Google Patents

Nuevos compuestos.

Info

Publication number
MX2016016371A
MX2016016371A MX2016016371A MX2016016371A MX2016016371A MX 2016016371 A MX2016016371 A MX 2016016371A MX 2016016371 A MX2016016371 A MX 2016016371A MX 2016016371 A MX2016016371 A MX 2016016371A MX 2016016371 A MX2016016371 A MX 2016016371A
Authority
MX
Mexico
Prior art keywords
novel compounds
therapy
relates
heterocyclic compounds
neutrophil elastase
Prior art date
Application number
MX2016016371A
Other languages
English (en)
Inventor
Armani Elisabetta
Capaldi Carmelida
Alcaraz Lilian
Andrew Heald Robert
Mark Sutton Jonathan
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of MX2016016371A publication Critical patent/MX2016016371A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención se refiere a compuestos heterocíclicos, que son derivados de pirimidinona que tienen propiedades inhibidoras de elastasa de neutrófilos humanos, y su uso en terapia.
MX2016016371A 2014-06-12 2014-06-12 Nuevos compuestos. MX2016016371A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/062254 WO2015188866A1 (en) 2014-06-12 2014-06-12 Novel compounds

Publications (1)

Publication Number Publication Date
MX2016016371A true MX2016016371A (es) 2017-05-01

Family

ID=50979740

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016371A MX2016016371A (es) 2014-06-12 2014-06-12 Nuevos compuestos.

Country Status (11)

Country Link
US (1) US9868740B2 (es)
EP (1) EP3154977B1 (es)
KR (1) KR20170016840A (es)
CN (1) CN106459054A (es)
CA (1) CA2951734A1 (es)
ES (1) ES2670018T3 (es)
MX (1) MX2016016371A (es)
PL (1) PL3154977T3 (es)
RU (1) RU2016148395A (es)
TR (1) TR201811041T4 (es)
WO (1) WO2015188866A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0605469D0 (en) * 2006-03-17 2006-04-26 Argenta Discovery Ltd Multimers of heterocyclic compounds and their use
GB201004179D0 (en) * 2010-03-12 2010-04-28 Pulmagen Therapeutics Inflamma Enzyme inhibitors
GB201004178D0 (en) 2010-03-12 2010-04-28 Pulmagen Therapeutics Inflamma Enzyme inhibitors
TWI568735B (zh) * 2011-09-14 2017-02-01 吉斯藥品公司 新穎化合物
EP2935274B1 (en) 2012-12-18 2018-10-03 Chiesi Farmaceutici S.p.A. 3-oxo-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine derivatives for the treatmetn of respiratory diseases

Also Published As

Publication number Publication date
WO2015188866A1 (en) 2015-12-17
RU2016148395A3 (es) 2018-07-12
ES2670018T3 (es) 2018-05-29
CA2951734A1 (en) 2015-12-17
KR20170016840A (ko) 2017-02-14
EP3154977B1 (en) 2018-05-02
EP3154977A1 (en) 2017-04-19
US20170101413A1 (en) 2017-04-13
CN106459054A (zh) 2017-02-22
TR201811041T4 (tr) 2018-08-27
RU2016148395A (ru) 2018-07-12
US9868740B2 (en) 2018-01-16
PL3154977T3 (pl) 2018-10-31

Similar Documents

Publication Publication Date Title
PH12015501043A1 (en) Novel compounds
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
MD20170032A2 (ro) Anticorpi anti-TIGIT
ZA201803742B (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
IL276733A (en) Use of Aribolin in cancer treatment
PH12018502242A1 (en) Imidazolone compounds as human neutrophil elastase inhibitors
SI3297628T1 (sl) Azasetron za uporabo pri zdravljenju izgube sluha
LT3377094T (lt) Susilpninto virulentiškumo bakterijos, skirtos piktybinių solidinių navikų gydymui
GB201417163D0 (en) Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
IL246880B (en) A combination of oxalipatin, leucovorin and 5- fluorouracil for treating cancer
MX382092B (es) Compuestos heterocíclicos para el tratamiento de enfermedades.
MX2017007676A (es) Nuevos compuestos.
HK1254231A1 (zh) 米托-和厚朴酚化合物及其合成方法和用途
BR112017018183A2 (pt) derivados de pirimidina como inibidores de quinase e suas aplicações terapêuticas.
IL253933A0 (en) History of pyrimidine use in the treatment of cancer
MX2016016371A (es) Nuevos compuestos.
PH12017501063A1 (en) Compounds for the treatment of cancer
MX2016016381A (es) Derivados de tetrahidrotriazolopirimidina, composiciones farmaceuticas que contienen los mismos y usos.
IL257350A (en) 5-bromo-2,6-di-(lh-pyrazol-l-yl)pyrimidin-4-amine for use in the treatment of cancer
EA201691620A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
HK1257141A1 (en) Varlitinib for use in the treatment of resistant or refractory cancer
HK1248110A1 (en) Plx-8394 or plx-7904 for use in the treatment of braf-v600-related diseases
GB2546703A (en) Compounds
LT3297628T (lt) Azasetronas, skirtas naudoti klausos praradimo gydymui